Hemophilia News TodayHow to Manage Hemophilia Joint Pain

⚠️ Rare but High Risk Safety Event

Hemarthrosis, bleeding into joint spaces, occurs in 70–80% of people with hemophilia and can progress to hemophilic arthropathy, causing permanent joint damage, muscle atrophy, and functional limitation. Factor replacement prophylaxis is the primary prevention strategy; pain management is the most common pharmacist intersection point with this population.

Counseling Priorities

• Aspirin is contraindicated in hemophilia; NSAIDs require prescriber supervision due to platelet inhibition amplifying bleeding risk; community pharmacists should intercept OTC requests from any patient disclosing hemophilia at the counter.
• Acute joint bleeds call for the RICE protocol (Rest, Ice, Compression, Elevation) as first-line home management; patients presenting with joint pain may be requesting OTC analgesics when RICE is the appropriate first step.
• Regularly scheduled factor replacement infusions are the primary prophylactic strategy; adherence gaps driven by undertreated anxiety or depression are a documented driver of joint damage progression.
• Hemophilia treatment centers, with more than 140 in the US, are the appropriate referral destination for joint bleed management; pharmacists should have the nearest center contact available for patients without established specialty care.

Counseling Applications

• Redirect patients with hemophilia requesting OTC aspirin or NSAIDs to acetaminophen and prescriber consultation before dispensing.
• Reinforce RICE protocol adherence for acute joint pain before escalating to any pharmacologic management.
• Screen for adherence barriers; depression and anxiety are documented reasons patients discontinue prophylactic factor regimens.
• Refer unestablished patients to a hemophilia treatment center; this is a specialty-managed condition and should not be self-directed.